Clinical Trial Update: A Study Comparing the Efficacy and Safety of Vanucizumab and FOLFOX With Bevacizumab and FOLFOX in Participants With Untreated Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial comparing vanucizumab+FOLFOX versus bevacizumab+FOLFOX in untreated metastatic colorectal cancer; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• FOLFOX
• Vanucizumab

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Colorectal Cancer | Phase 2 | Status: TERMINATED | Results posted: 2020-03-25